MiMedx Group, Inc.

Healthcare · Biotechnology · United States

Last price 3.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 566.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The co...